BRIEF-Camurus Receives Approval In Canada For Oczyesa XR

1

Oct 12 (Reuters) – Camurus AB: * CAMURUS RECEIVES APPROVAL IN CANADA FOR OCZYESA® XR, A ONCE-MONTHLY, SELF-ADMINISTERED TREATMENT FOR ACROMEGALY Source text: Further company coverage: (Gdansk Newsroom

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)